On the other hand, germline mutations in BRCA2 or CDKN2A have been suggested as explanations for the link between MM and breast cancer, and CDKN2A mutations have also been proposed as a cause of the increased risk of pancreatic cancer. The gene discussed is BRCA2; the disease is Miyoshi myopathy.